High Containment Pharmaceutical Operations
Our High Containment Operations (HCO) handle highly potent compounds through a closed manufacturing system with a capability of handling substances down to an occupational exposure level (OEL) of 0.1 µg/m3 or less. We currently have multiple dedicated processing suites and supporting infrastructure along with a dedicated packing room, remote data acquisition system, and documentation room. For each chemical moiety introduced, aggressive assessment studies are performed to ensure there is no contamination.
Our analytical testing labs are furnished with appropriate equipment such as safety work benches for sample preparations, containment hoods and isolators for testing samples, and separation from the normal lab areas and with limited access.
Stason complies with all applicable laws with respect to the environment, occupational health and safety, public health and safety, and waste disposal, and holds all current and applicable governmental licenses, approvals, permits and authorizations.
Stason currently references the SafeBridge® categorization scheme and works with SafeBridge® Category 1-4 compounds.
The SafeBridge “Occupational Health Toxicity / Potency Categorization and Handling Practices” system (copyright SafeBridge Consultants, Inc., Fifth Revision – January 2002, pp.12, is a four-category system to characterize compound potency.